Yanjun Mi
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Sensory Systems top 10%
Papers in
-
- Protein Degradation and Inhibitors 4
- RNA modifications and cancer 4
- Epigenetics and DNA Methylation 3
- Oncology 12
- Cancer-related Molecular Pathways 4
- Co-authors
- Zhengzhi Zou (11 shared papers)Yibing Chen (9 shared papers)Yucen Song (3 shared papers)Haolong Li (3 shared papers)Qian Ma (2 shared papers)Benxin Hou (4 shared papers)Xiaofei Zhang (1 shared paper)Wei Du (1 shared paper)
- Journals
- Oncotarget (4 papers)Cancer Management and Research (2 papers)Cancer Research (2 papers)Journal of Experimental & Clinical Cancer Research (2 papers)Journal of Clinical Oncology (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Yanjun Mi
39 papers receiving 1.1k citations
Yanjun Mi's Hit Papers
Peers
Comparison fields: 5 of 100
- Cancer Research 329
- Sensory Systems 50
- Pulmonary and Respiratory Medicine 293
- Oncology 215
- Molecular Biology 564
Countries citing papers authored by Yanjun Mi
This map shows the geographic impact of Yanjun Mi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanjun Mi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanjun Mi more than expected).
Fields of papers citing papers by Yanjun Mi
This network shows the impact of papers produced by Yanjun Mi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanjun Mi. The network helps show where Yanjun Mi may publish in the future.
Co-authors
The 25 scholars most cited alongside Yanjun Mi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Dihydroartemisinin-induced unfolded protein response feedback attenuates ferroptosis via PERK/ATF4/HSPA5 pathway in glioma cells Hit paper breakdown → | 2019 | 268 |
| 2 | 2021 | 101 | |
| 3 | 2015 | 63 | |
| 4 | 2016 | 52 | |
| 5 | 2020 | 51 | |
| 6 | 2016 | 48 | |
| 7 | 2020 | 46 | |
| 8 | 2018 | 44 | |
| 9 | 2014 | 33 | |
| 10 | 2017 | 32 | |
| 11 | 2022 | 28 | |
| 12 | 2020 | 28 | |
| 13 | 2023 | 26 | |
| 14 | 2010 | 26 | |
| 15 | 2020 | 25 | |
| 16 | 2021 | 23 | |
| 17 | 2021 | 21 | |
| 18 | 2017 | 21 | |
| 19 | 2018 | 20 | |
| 20 | 2016 | 19 |
About Yanjun Mi
Yanjun Mi is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Pathology and Forensic Medicine, having authored 40 papers that have together received 1.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (7 papers), Ferroptosis and cancer prognosis (5 papers), Cancer Mechanisms and Therapy (4 papers), Cancer-related molecular mechanisms research (4 papers), Protein Degradation and Inhibitors (4 papers), Cancer-related Molecular Pathways (4 papers), RNA modifications and cancer (4 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Cancer Research (329 citations), Sensory Systems (50 citations), Pulmonary and Respiratory Medicine (293 citations), Oncology (215 citations) and Molecular Biology (564 citations). Yanjun Mi has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Zhengzhi Zou, Yibing Chen, Yucen Song, Haolong Li, Qian Ma, Benxin Hou, Xiaofei Zhang, Wei Du, Dandan Wang and Huan Jin. Their work appears in journals such as Oncotarget, Cancer Management and Research, Cancer Research, Journal of Experimental & Clinical Cancer Research and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.